Production and characterization of a fusion peptide derived from the rabies virus glycoprotein (RVG29)

Protein Expression and Purification

Volumn 104, Issue , 2014, Pages 7-13

  Yang, Yu Jiao ^a   Zhao, Ping Sen ^b,c   Wu, Hong Xia ^b   Wang, Hua Lei ^b   Zhao, Li Li ^b   Xue, Xiang Hong ^b   Gai, Wei Wei ^b   Gao, Yu Wei ^b   Yang, Song Tao ^b   Xia, Xian Zhu ^b  

^a SOUTHWEST UNIVERSITY   (China)

^b BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^c MEIZHOU HOSPITAL AFFILIATED TO SUN YAT SEN UNIVERSITY   (China)

Author keywords

Brain; Gene delivery; Rabies; RVG29 oligoarginine peptide

Indexed keywords

DNA; GLYCOPROTEIN; HYBRID PROTEIN; PEPTIDE FRAGMENT; RABIES VIRUS GLYCOPROTEIN PEPTIDE; VIRAL PROTEIN; VIRUS ENVELOPE PROTEIN;

ANIMAL; CELL LINE; CELL SURVIVAL; GENETICS; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; MOUSE; PLASMID; PROTEIN STABILITY; RABIES VIRUS;

ANIMALS; CELL LINE; CELL SURVIVAL; DNA; GLYCOPROTEINS; HUMANS; MICE; PEPTIDE FRAGMENTS; PLASMIDS; PROTEIN STABILITY; RABIES VIRUS; RECOMBINANT FUSION PROTEINS; VIRAL ENVELOPE PROTEINS; VIRAL PROTEINS;

EID: 84907808645     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2014.09.001     Document Type: Article

References (29)

1. M. Teixido, and E. Giralt The role of peptides in blood-brain barrier nanotechnology J. Pept. Sci. 14 2008 163 173
2. I. Posadas, F.J. Guerra, and V. Cena Nonviral vectors for the delivery of small interfering RNAs to the CNS Nanomedicine (Lond.) 5 2010 1219 1236
3. H.L. Wong, X.Y. Wu, and R. Bendayan Nanotechnological advances for the delivery of CNS therapeutics Adv. Drug Deliv. Rev. 64 2012 686 700
4. C. Lundberg, T. Bjorklund, T. Carlsson, J. Jakobsson, P. Hantraye, N. Deglon, and D. Kirik Applications of lentiviral vectors for biology and gene therapy of neurological disorders Curr. Gene Ther. 8 2008 461 473
5. B. Anliker, T. Abel, S. Kneissl, J. Hlavaty, A. Caputi, J. Brynza, I.C. Schneider, R.C. Munch, H. Petznek, R.E. Kontermann, U. Koehl, I.C. Johnston, K. Keinanen, U.C. Muller, C. Hohenadl, H. Monyer, K. Cichutek, and C.J. Buchholz Specific gene transfer to neurons, endothelial cells and hematopoietic progenitors with lentiviral vectors Nat. Methods 7 2010 929 935
6. S.H. Chen, H.D. Shine, J.C. Goodman, R.G. Grossman, and S.L. Woo Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo Proc. Natl. Acad. Sci. U.S.A. 91 1994 3054 3057
7. S. Lehrman Virus treatment questioned after gene therapy death Nature 401 1999 517 518
8. P.H. Kim, T.I. Kim, J.W. Yockman, S.W. Kim, and C.O. Yun The effect of surface modification of adenovirus with an arginine-grafted bioreducible polymer on transduction efficiency and immunogenicity in cancer gene therapy Biomaterials 31 2010 1865 1874
9. S.K. Kim, K.M. Park, K. Singha, J. Kim, Y. Ahn, K. Kim, and W.J. Kim Galactosylated cucurbituril-inclusion polyplex for hepatocyte-targeted gene delivery Chem. Commun. (Camb.) 46 2010 692 694
10. J. Luten, C.F. van Nostrum, S.C. De Smedt, and W.E. Hennink Biodegradable polymers as non-viral carriers for plasmid DNA delivery J. Control. Release 126 2008 97 110
11. S.L. Lo, and S. Wang An endosomolytic Tat peptide produced by incorporation of histidine and cysteine residues as a nonviral vector for DNA transfection Biomaterials 29 2008 2408 2414
12. P. Kumar, H. Wu, J.L. McBride, K.E. Jung, M.H. Kim, B.L. Davidson, S.K. Lee, P. Shankar, and N. Manjunath Transvascular delivery of small interfering RNA to the central nervous system Nature 448 2007 39 43
13. M. Lafon Rabies virus receptors J. Neurovirol. 11 2005 82 87
14. T.L. Lentz, T.G. Burrage, A.L. Smith, J. Crick, and G.H. Tignor Is the acetylcholine receptor a rabies virus receptor? Science 215 1982 182 184
15. S.S. Kim, C. Ye, P. Kumar, I. Chiu, S. Subramanya, H. Wu, P. Shankar, and N. Manjunath Targeted delivery of siRNA to macrophages for anti-inflammatory treatment Mol. Ther. 18 2010 993 1001
16. W. Hwang do, S. Son, J. Jang, H. Youn, S. Lee, D. Lee, Y.S. Lee, J.M. Jeong, W.J. Kim, and D.S. Lee A brain-targeted rabies virus glycoprotein-disulfide linked PEI nanocarrier for delivery of neurogenic microRNA Biomaterials 32 2011 4968 4975
17. Y. Liu, R. Huang, L. Han, W. Ke, K. Shao, L. Ye, J. Lou, and C. Jiang Brain-targeting gene delivery and cellular internalization mechanisms for modified rabies virus glycoprotein RVG29 nanoparticles Biomaterials 30 2009 4195 4202
18. L. Alvarez-Erviti, Y. Seow, H. Yin, C. Betts, S. Lakhal, and M.J. Wood Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes Nat. Biotechnol. 29 2011 341 345
19. B. Pulford, N. Reim, A. Bell, J. Veatch, G. Forster, H. Bender, C. Meyerett, S. Hafeman, B. Michel, T. Johnson, A.C. Wyckoff, G. Miele, C. Julius, J. Kranich, A. Schenkel, S. Dow, and M.D. Zabel Liposome-siRNA-peptide complexes cross the blood-brain barrier and significantly decrease PrP on neuronal cells and PrP in infected cell cultures PLoS ONE 5 2010 e11085
20. S. Son, W. Hwang do, K. Singha, J.H. Jeong, T.G. Park, D.S. Lee, and W.J. Kim RVG peptide tethered bioreducible polyethylenimine for gene delivery to brain J. Control. Release 155 2011 18 25
21. C. Gong, X. Li, L. Xu, and Y.H. Zhang Target delivery of a gene into the brain using the RVG29-oligoarginine peptide Biomaterials 33 2012 3456 3463
22. Y. Chen, and L. Liu Modern methods for delivery of drugs across the blood-brain barrier Adv. Drug Deliv. Rev. 64 2012 640 665
23. A. El-Sayed, I.A. Khalil, K. Kogure, S. Futaki, and H. Harashima Octaarginine- and octalysine-modified nanoparticles have different modes of endosomal escape J. Biol. Chem. 283 2008 23450 23461
24. W.Y. Seow, Y.Y. Yang, and A.J. George Oligopeptide-mediated gene transfer into mouse corneal endothelial cells: expression, design optimization, uptake mechanism and nuclear localization Nucleic Acids Res. 37 2009 6276 6289
25. A.K. Varkouhi, M. Scholte, G. Storm, and H.J. Haisma Endosomal escape pathways for delivery of biologicals J. Control. Release 151 2011 220 228
26. J.W. Yoo, N. Doshi, and S. Mitragotri Adaptive micro and nanoparticles: temporal control over carrier properties to facilitate drug delivery Adv. Drug Deliv. Rev. 63 2011 1247 1256
27. H.S. Choi, W. Liu, P. Misra, E. Tanaka, J.P. Zimmer, B. Itty Ipe, M.G. Bawendi, and J.V. Frangioni Renal clearance of quantum dots Nat. Biotechnol. 25 2007 1165 1170
28. S. Wang, H. Song, W.Y. Ong, M.Y. Han, and D. Huang Positively charged and pH self-buffering quantum dots for efficient cellular uptake by charge mediation and monitoring cell membrane permeability Nanotechnology 20 2009 425102
29. E.Y. Chi, S. Krishnan, T.W. Randolph, and J.F. Carpenter Physical stability of proteins in aqueous solution: mechanism and driving forces in nonnative protein aggregation Pharm. Res. 20 2003 1325 1336